Novartis Still Thinking Alcon Spinoff…In 2019

Earlier this year Novartis (NVS) CEO Joe Jimenez said the company was considering a sale or a spinoff of Alcon, its surgical equipment and eye care business. The company paid a hefty penny (actually ~$50b worth of pennies) to acquire the business back in 2010, but as with a lot of M&A, things haven’t gone as planned. Many… Read More »